Original Literature | Model OverView |
---|---|
Publication
Title
Differential responses of human monocytes and macrophages to IL-4 and IL-13.
Affiliation
Department of Microbiology & Infectious Diseases, School of Medicine, FlindersUniversity of South Australia, Adelaide, Australia.
Abstract
The primary interleukin-4 (IL-4) receptor complex on monocytes (type I IL-4receptor) includes the 140-kDa alpha chain (IL-4R alpha) and the IL-2 receptorgamma chain, gamma(c), which heterodimerize for intracellular signaling,resulting in suppression of lipopolysaccharide (LPS)-inducible inflammatorymediator production. The activity of IL-13 on human monocytes is very similar tothat of IL-4 because the predominant signaling chain (IL-4R alpha) is common toboth receptors. In fact, IL-4R alpha with IL-13R alpha1 is designated both as anIL-13 receptor and the type II IL-4 receptor. When the anti-inflammatoryactivities of IL-4 and IL-13 were investigated on synovial fluid macrophages andcompared with the responses by monocytes isolated from the patients at the sametime as joint drainage, the response profiles differed with some responsessimilar in the two cell populations, others reduced on the inflammatory cells.Similar differences were recorded in the response profiles to IL-4 and IL-13 bymonocytes and monocytes cultured for 7 days in macrophage colony-stimulatingfactor (M-CSF) or granulocyte-macrophage CSF (GM-CSF) (monocyte-derivedmacrophages, MDMac). MDMac have reduced gamma(c) mRNA levels and reducedexpression of the functional 64-kDa gamma(c). There was a similar loss of IL-13Ralpha1 mRNA on monocyte differentiation. In turn, there was a significantreduction in the ability of IL-4 and IL-13 to activate STAT6. These findingssuggest that different functional responses to IL-4 and IL-13 by human monocytesand macrophages may result from reduced expression of gamma(c) and IL-13Ralpha1.
PMID
10534111
|
Entity
TNF-alpha
--
G010329
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93309
10
infinite
0
TRANSFAC | G010329 |
--
STATs
--
MO000016656
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1633
10
infinite
0
TRANSPATH | MO000016656 |
--
IL-4Ralpha
--
MO000017058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1951
10
infinite
0
InterPro | IPR003961 |
TRANSPATH | MO000017058 |
--
IL-4:IL-4Ralpha
--
MO000034134
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m12691
10
infinite
0
TRANSPATH | MO000034134 |
--
IL-13Ralpha1
--
MO000045621
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m23256
10
infinite
0
InterPro | IPR003532 |
TRANSPATH | MO000045621 |
--
IL-13Ralpha2
--
MO000045622
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m23257
10
infinite
0
InterPro | IPR003532 |
TRANSPATH | MO000045622 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
LPS:TLR4
--
e11
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m11
0
infinite
0
--
IL-2Rgamma:IL-2Rbeta
--
e12
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m12
0
infinite
0
--
t-PA
--
e13
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m13
0
infinite
0
--
csml-variable:Double
m14
0
infinite
0
--
PGE2
--
e15
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m15
0
infinite
0
--
csml-variable:Double
m16
0
infinite
0
--
IL-13:IL-13Ralpha1
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m17
0
infinite
0
--
IL-13:IL-13Ralpha1:IL-4Ralpha
--
e18
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m18
0
infinite
0
--
IL-13:IL-13Ralpha1:IL-4Ralpha:JAK1:STAT6
--
e19
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
IL-13:IL-13Ralpha1:IL-4Ralpha:JAK1
--
e20
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m20
0
infinite
0
--
IL-4:IL-4Ralpha:IL-13Ralpha1
--
e21
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m21
0
infinite
0
--
Il-13:IL-13Ralpha2
--
e22
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m22
0
infinite
0
--
IL-13:IL-13Ralpha1:IL-4Ralpha:JAK1
--
e24
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m24
0
infinite
0
--
IFNgammaR
--
e25
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m25
0
infinite
0
--
IFNgamma:receptor
--
e26
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m26
0
infinite
0
--
GM-CSF:GM-CSFR
--
e27
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m27
0
infinite
0
--
IL-10:IL-10R
--
e28
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m28
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IL-12
--
e30
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m30
0
infinite
0
--
IL-4{mutant}:IL-4Ralpha
--
e33
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m33
10
infinite
0
TRANSPATH | MO000034134 |
--
Neutralizing antibiody
--
e34
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m34
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
IL-2Rgamma
--
e5
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
IL4:IL-4Ralpha:IL-2Rgamma
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 10534111 LPS binds its receptor TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m23256*m836*0.1
nodelay
--
0
PMID: 10534111, 8910586, 9013879 The IL-13Ra1 chain has weak IL-13 binding capacity on its own but binds IL-13 strongly on complexing with the IL-4Ra chain [26, 27].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m17*m1951*0.1
nodelay
--
0
PMID: 10534111, 8910586, 9013879 The IL-13Ra1 chain has weak IL-13 binding capacity on its own but binds IL-13 strongly on complexing with the IL-4Ra chain [26, 27].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c36 : 1
stoichiometry:c35 : 1
m18*0.1
nodelay
--
0
PMID: 10534111 For IL-13, the second bound receptor chain (IL-4Ra) functions to recruit JAK1 to the receptor complex, and to provide a docking site for STAT6 on its intracellular domain and thus provides a mechanism by which the biological effects of IL-4 and IL-13 on monocytes are very similar.
p13
p13
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m20*m1368*0.1
nodelay
--
0
PMID: 10534111 For IL-13, the second bound receptor chain (IL-4Ra) functions to recruit JAK1 to the receptor complex, and to provide a docking site for STAT6 on its intracellular domain and thus provides a mechanism by which the biological effects of IL-4 and IL-13 on monocytes are very similar.
p14
p14
cso30:i:ME_Dimerization
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m12691*m23256*0.1
nodelay
--
0
PMID: 10534111, 9573026 There is strong evidence particularly on non-hematopoietic cells that the IL-4Ra chain on binding to IL-4 can heterodimerize with the IL-13Ra1 chain forming the type II IL-4 receptor [28].
p15
p15
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m836*m23257*0.1
nodelay
--
0
PMID: 10534111, 8663118 A second IL-13-specific receptor chain, IL-13Ra2, has been cloned from a human renal carcinoma cell line and binds IL-13 with much higher affinity [29].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m19*0.1
nodelay
--
0
PMID: 10534111, 9558115, 10427971 The loss of IL-4- and IL-13-induced STAT6 activation with monocyte differentiation was unique because STATs activated by IFN-g, GM-CSF, and IL-10 were not altered with monocyte culture [16, 17].
p17
p17
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m6*m1368*0.1
nodelay
--
0
PMID: 10534111, 9558115, 10427971 The loss of IL-4- and IL-13-induced STAT6 activation with monocyte differentiation was unique because STATs activated by IFN-g, GM-CSF, and IL-10 were not altered with monocyte culture [16, 17].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m1639*m25*0.1
nodelay
--
0
PMID: 10534111 IFN-gamma binds its corresponding receptor.
p19
p19
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
stoichiometry:c58 : 1
m88*m81*0.1
nodelay
--
0
PMID: 10534111 GM-CSF binds its corresponding receptor.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c21 : 1
stoichiometry:c8 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 2786204, 2120129, 2785566, 9558115, 10427971, 9558115, 10427971 2114443 IL-4 inhibited the production of lipopolysaccharide (LPS)-stimulated tumor necrosis factor a (TNF-a), IL-1b, IL-6, IL-10, and prostaglandin E2 (PGE2) [1?4] by monocytes and this regulation occurred for the peptides, at least in part, at the mRNA level. Furthermore, in kinetic studies of mRNA levels for gc and IL-13Ra1 with increasing time of culture for monocytes, as mRNA levels were reduced so too was the ability of IL-4 and IL-13 to suppress LPS-induced TNF-a production [16, 17].
p20
p20
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m2103*m2108*0.1
nodelay
--
0
PMID: 10534111 IL-10 binds its corresponding receptor.
p21
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m1633*m26*0.1
nodelay
--
0
PMID: 10534111, 9558115, 10427971 The loss of IL-4- and IL-13-induced STAT6 activation with monocyte differentiation was unique because STATs activated by IFN-g, GM-CSF, and IL-10 were not altered with monocyte culture [16, 17].
p21
p22
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m27*m1633*0.1
nodelay
--
0
PMID: 10534111, 9558115, 10427971 The loss of IL-4- and IL-13-induced STAT6 activation with monocyte differentiation was unique because STATs activated by IFN-g, GM-CSF, and IL-10 were not altered with monocyte culture [16, 17].
p21
p23
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c70 : 1
stoichiometry:c69 : 1
m1633*m28*0.1
nodelay
--
0
PMID: 10534111, 9558115, 10427971 The loss of IL-4- and IL-13-induced STAT6 activation with monocyte differentiation was unique because STATs activated by IFN-g, GM-CSF, and IL-10 were not altered with monocyte culture [16, 17].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c73 : 1
stoichiometry:c72 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 9558115, 10427971 Furthermore, in kinetic studies of mRNA levels for gc and IL-13Ra1 with increasing time of culture for monocytes, as mRNA levels were reduced so too was the ability of IL-4 and IL-13 to suppress LPS-induced TNF-a production [16, 17].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c74 : 1
m26*0.1
nodelay
--
0
PMID: 10534111, 10227996 It was recently shown that IL-4 could regulate TNF-a and IL-12 production by IFN-g-activated murine bone marrow-derived macrophages from STAT6-/- mice [31].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c79 : 1
stoichiometry:c78 : 1
m26*0.1
nodelay
--
0
PMID: 10534111, 10227996 It was recently shown that IL-4 could regulate TNF-a and IL-12 production by IFN-g-activated murine bone marrow-derived macrophages from STAT6-/- mice [31].
p27
p27
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c93 : 1
stoichiometry:c83 : 1
m11*0.1
nodelay
--
0
PMID: 10534111 First, a neutralizing antibody to gc blocked IL-4 regulation of LPSinduced TNF-a, but not IL-1b, production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m32*m1951*0.1
nodelay
--
0
PMID: 10534111 Second, a mutant IL-4 molecule that was able to bind the IL-4Ra chain but not gc suppressed LPS-induced monocyte IL-1b, but not TNF-a, production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m11*0.1
nodelay
--
0
PMID: 10534111 Second, a mutant IL-4 molecule that was able to bind the IL-4Ra chain but not gc suppressed LPS-induced monocyte IL-1b, but not TNF-a, production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c5 : 1
stoichiometry:c23 : 1
stoichiometry:c9 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 2786204, 2120129, 2785566, 2114443 IL-4 inhibited the production of lipopolysaccharide (LPS)-stimulated tumor necrosis factor a (TNF-a), IL-1b, IL-6, IL-10, and prostaglandin E2 (PGE2) [1?4] by monocytes and this regulation occurred for the peptides, at least in part, at the mRNA level.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
stoichiometry:c90 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 10427971 From studies using an antibody to the IL-4Ra chain, we know that this chain is a component of the receptor by which IL-4 and IL-13 signal suppression of LPS-induced IL-1b production by MDMac [17].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c95 : 1
stoichiometry:c94 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 2786204, 2120129, 2785566, 9558115, 10427971, 9558115, 10427971 2114443 IL-4 inhibited the production of lipopolysaccharide (LPS)-stimulated tumor necrosis factor a (TNF-a), IL-1b, IL-6, IL-10, and prostaglandin E2 (PGE2) [1?4] by monocytes and this regulation occurred for the peptides, at least in part, at the mRNA level.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c24 : 1
stoichiometry:c10 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 2786204, 2120129, 2785566, 2114443 IL-4 inhibited the production of lipopolysaccharide (LPS)-stimulated tumor necrosis factor a (TNF-a), IL-1b, IL-6, IL-10, and prostaglandin E2 (PGE2) [1?4] by monocytes and this regulation occurred for the peptides, at least in part, at the mRNA level.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c22 : 1
stoichiometry:c82 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 2786204, 2120129, 2785566, 2114443 IL-4 inhibited the production of lipopolysaccharide (LPS)-stimulated tumor necrosis factor a (TNF-a), IL-1b, IL-6, IL-10, and prostaglandin E2 (PGE2) [1?4] by monocytes and this regulation occurred for the peptides, at least in part, at the mRNA level.
p6
p6
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m1947*m1951*0.1
nodelay
--
0
PMID: 10534111, 9573026 It is believed that a site within the A/C helices of IL-4 first binds the IL-4Ra chain with high affinity. A site located near the end of helix D then binds gc, creating an active receptor dimer; mutations of the tyrosine at position 124 greatly reduces this interaction. There is strong evidence particularly on non-hematopoietic cells that the IL-4Ra chain on binding to IL-4 can heterodimerize with the IL-13Ra1 chain forming the type II IL-4 receptor [28].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c17 : 1
m12691*m5*0.1
nodelay
--
0
PMID: 10534111 It is believed that a site within the A/C helices of IL-4 first binds the IL-4Ra chain with high affinity. A site located near the end of helix D then binds gc, creating an active receptor dimer; mutations of the tyrosine at position 124 greatly reduces this interaction.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c19 : 1
stoichiometry:c20 : 1
m5*m2081*0.1
nodelay
--
0
PMID: 10534111, 7843245 Western blots of gc on monocytes suggested proteins of 58 and 64 kDa but only the 64 kDa protein could associate with the IL-2Rb chain [23].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c49 : 1
stoichiometry:c27 : 1
m13*m11*0.1
nodelay
--
0
PMID: 10534111, 2786204, 2120129, 2785566, 2114443 IL-4 inhibited the production of lipopolysaccharide (LPS)-stimulated tumor necrosis factor a (TNF-a), IL-1b, IL-6, IL-10, and prostaglandin E2 (PGE2) [1?4] by monocytes and this regulation occurred for the peptides, at least in part, at the mRNA level.
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--